| Dr James T Kim, MD | |
|
754 Medical Center Ct Ste 101, Chula Vista, CA 91911-6655 | |
| (619) 434-4288 | |
| (619) 434-4315 |
| Full Name | Dr James T Kim |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 15 Years |
| Location | 754 Medical Center Ct Ste 101, Chula Vista, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336378371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A121180 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sharp Chula Vista Medical Center | Chula vista, CA | Hospital |
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.
The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
› Verified 4 days ago
| Entity Name | Telemedicine Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326338237 PECOS PAC ID: 9830351824 Enrollment ID: O20120509000349 |
News Archive
Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.
The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
› Verified 4 days ago
| Entity Name | San Diego Heart Center A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861949828 PECOS PAC ID: 4082957899 Enrollment ID: O20190520000431 |
News Archive
Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.
The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James T Kim, MD 1415 E 8th St Ste 3, National City, CA 91950-2663 Ph: () - | Dr James T Kim, MD 754 Medical Center Ct Ste 101, Chula Vista, CA 91911-6655 Ph: (619) 434-4288 |
News Archive
Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.
The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
› Verified 4 days ago
Dr. Perry V Montoya, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 525 3rd Ave, Chula Vista, CA 91910 Phone: 858-499-2600 Fax: 619-585-4353 | |
John S Videen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 752 Medical Center Ct, Suite 302, Chula Vista, CA 91911 Phone: 619-421-3361 Fax: 619-656-8936 | |
Daniel Cepin, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 890 Eastlake Pkwy, Suite 205, Chula Vista, CA 91914 Phone: 619-482-0300 Fax: 619-482-0959 | |
Kenneth Burton Johnson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 769 Medical Center Ct, Suite 202, Chula Vista, CA 91911 Phone: 619-482-8430 Fax: 619-482-8005 | |
Dr. Michael Sonbaty, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 858-499-2616 | |
Sara Khandan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Alejandro G Hinojosa, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 340 4th Ave, Suite 8, Chula Vista, CA 91910 Phone: 619-216-7546 Fax: 619-216-7783 |